These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10573132)

  • 1. Bax:Bcl-2 ratio modulation by bryostatin 1 and novel antitubulin agents is important for susceptibility to drug induced apoptosis in the human early pre-B acute lymphoblastic leukemia cell line, Reh.
    Wall NR; Mohammad RM; Al-Katib AM
    Leuk Res; 1999 Oct; 23(10):881-8. PubMed ID: 10573132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of cIAP-1 by novel antitubulin agents when combined with bryostatin 1 results in increased apoptosis in the human early pre-B acute lymphoblastic leukemia cell line Reh.
    Wall NR; Mohammad RM; Nabha SM; Pettit GR; Al-Katib AM
    Biochem Biophys Res Commun; 1999 Dec; 266(1):76-80. PubMed ID: 10581168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of 2-chlorodeoxyadenosine activity by bryostatin 1 in the resistant chronic lymphocytic leukemia cell line (WSU-CLL): association with increased ratios of dCK/5'-NT and Bax/Bcl-2.
    Mohammad RM; Beck FW; Katato K; Hamdy N; Wall N; Al-Katib A
    Biol Chem; 1998 Oct; 379(10):1253-61. PubMed ID: 9820586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bryostatin 1 induces ubiquitination and proteasome degradation of Bcl-2 in the human acute lymphoblastic leukemia cell line, Reh.
    Wall NR; Mohammad RM; Reddy KB; Al-Katib AM
    Int J Mol Med; 2000 Feb; 5(2):165-71. PubMed ID: 10639596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of human chronic lymphocytic leukemia xenografts with combination biological agents auristatin PE and bryostatin 1.
    Mohammad RM; Varterasian ML; Almatchy VP; Hannoudi GN; Pettit GR; Al-Katib A
    Clin Cancer Res; 1998 May; 4(5):1337-43. PubMed ID: 9607595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic interaction of selected marine animal anticancer drugs against human diffuse large cell lymphoma.
    Mohammad RM; Pettit GR; Almatchy VP; Wall N; Varterasian M; Al-Katib A
    Anticancer Drugs; 1998 Feb; 9(2):149-56. PubMed ID: 9510501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model.
    Mohammad RM; Wall NR; Dutcher JA; Al-Katib AM
    Clin Cancer Res; 2000 Dec; 6(12):4950-6. PubMed ID: 11156256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The bcl-2 and p53 oncoproteins can be modulated by bryostatin 1 and dolastatins in human diffuse large cell lymphoma.
    Maki A; Diwakaran H; Redman B; al-Asfar S; Pettit GR; Mohammad RM; al-Katib A
    Anticancer Drugs; 1995 Jun; 6(3):392-7. PubMed ID: 7670136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 and protein kinase C independent induction of growth arrest and apoptosis by bryostatin 1 in a highly metastatic mammary epithelial cell line: In vitro versus in vivo activity.
    Wang H; Mohammad RM; Werdell J; Shekhar PV
    Int J Mol Med; 1998 Jun; 1(6):915-23. PubMed ID: 9852625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agents that down-regulate or inhibit protein kinase C circumvent resistance to 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human leukemia cells that overexpress Bcl-2.
    Wang S; Vrana JA; Bartimole TM; Freemerman AJ; Jarvis WD; Kramer LB; Krystal G; Dent P; Grant S
    Mol Pharmacol; 1997 Dec; 52(6):1000-9. PubMed ID: 9396780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bryostatin 1 induces apoptosis and augments inhibitory effects of vincristine in human diffuse large cell lymphoma.
    Mohammad RM; Diwakaran H; Maki A; Emara MA; Pettit GR; Redman B; al-Katib A
    Leuk Res; 1995 Sep; 19(9):667-73. PubMed ID: 7564478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bryostatin 1 and UCN-01 potentiate 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human myeloid leukemia cells through disparate mechanisms.
    Wang S; Wang Z; Grant S
    Mol Pharmacol; 2003 Jan; 63(1):232-42. PubMed ID: 12488556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bryostatin induces protein kinase C modulation, Mcl-1 up-regulation and phosphorylation of Bcl-2 resulting in cellular differentiation and resistance to drug-induced apoptosis in B-cell chronic lymphocytic leukemia cells.
    Thomas A; Pepper C; Hoy T; Bentley P
    Leuk Lymphoma; 2004 May; 45(5):997-1008. PubMed ID: 15291360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bryostatin 1 increases 1-beta-D-arabinofuranosylcytosine-induced cytochrome c release and apoptosis in human leukemia cells ectopically expressing Bcl-x(L).
    Wang Z; Wang S; Dai Y; Grant S
    J Pharmacol Exp Ther; 2002 May; 301(2):568-77. PubMed ID: 11961058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bryostatin 1 enhances paclitaxel-induced mitochondrial dysfunction and apoptosis in human leukemia cells (U937) ectopically expressing Bcl-xL.
    Wang S; Wang Z; Boise LH; Dent P; Grant S
    Leukemia; 1999 Oct; 13(10):1564-73. PubMed ID: 10516758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic determinants of resistance to etoposide regulation of Bcl-X(L) and Bax by tumor microenvironmental factors.
    Taylor ST; Hickman JA; Dive C
    J Natl Cancer Inst; 2000 Jan; 92(1):18-23. PubMed ID: 10620629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bryostatin and CD40-ligand enhance apoptosis resistance and induce expression of cell survival genes in B-cell chronic lymphocytic leukaemia.
    Kitada S; Zapata JM; Andreeff M; Reed JC
    Br J Haematol; 1999 Sep; 106(4):995-1004. PubMed ID: 10520003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitogen-activated protein kinase is required for bryostatin 1-induced differentiation of the human acute lymphoblastic leukemia cell line Reh.
    Wall NR; Mohammad RM; Al-Katib AM
    Cell Growth Differ; 2001 Dec; 12(12):641-7. PubMed ID: 11751459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of bryostatin 1 on taxol-induced apoptosis and cytotoxicity in human leukemia cells (U937).
    Wang S; Guo CY; Castillo A; Dent P; Grant S
    Biochem Pharmacol; 1998 Sep; 56(5):635-44. PubMed ID: 9783732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of AS101 on bryostatin 1-mediated differentiation induction, cell cycle arrest, and modulation of drug-induced apoptosis in human myeloid leukemia cells.
    Rao AS; Freemerman AJ; Jarvis WD; Chelliah J; Bear HD; Mikkelsen R; Grant S
    Leukemia; 1996 Jul; 10(7):1150-8. PubMed ID: 8683995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.